Inspire Medical Systems SG&A Expenses 2017-2024 | INSP
Inspire Medical Systems annual/quarterly sg&a expenses history and growth rate from 2017 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Inspire Medical Systems sg&a expenses for the quarter ending March 31, 2024 were $0.126B, a 23.17% increase year-over-year.
- Inspire Medical Systems sg&a expenses for the twelve months ending March 31, 2024 were $0.476B, a 32.44% increase year-over-year.
- Inspire Medical Systems annual sg&a expenses for 2023 were $0.452B, a 40.93% increase from 2022.
- Inspire Medical Systems annual sg&a expenses for 2022 were $0.321B, a 58.27% increase from 2021.
- Inspire Medical Systems annual sg&a expenses for 2021 were $0.203B, a 58.45% increase from 2020.
| Inspire Medical Systems Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $452 |
| 2022 | $321 |
| 2021 | $203 |
| 2020 | $128 |
| 2019 | $90 |
| 2018 | $54 |
| 2017 | $32 |
| 2016 | $23 |
| Inspire Medical Systems Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-03-31 | $126 |
| 2023-12-31 | $124 |
| 2023-09-30 | $113 |
| 2023-06-30 | $113 |
| 2023-03-31 | $102 |
| 2022-12-31 | $95 |
| 2022-09-30 | $86 |
| 2022-06-30 | $77 |
| 2022-03-31 | $64 |
| 2021-12-31 | $59 |
| 2021-09-30 | $53 |
| 2021-06-30 | $49 |
| 2021-03-31 | $42 |
| 2020-12-31 | $39 |
| 2020-09-30 | $33 |
| 2020-06-30 | $27 |
| 2020-03-31 | $29 |
| 2019-12-31 | $28 |
| 2019-09-30 | $22 |
| 2019-06-30 | $20 |
| 2019-03-31 | $20 |
| 2018-12-31 | $16 |
| 2018-09-30 | $13 |
| 2018-06-30 | $13 |
| 2018-03-31 | $11 |
| 2017-12-31 | $10 |
| 2017-09-30 | $8 |
| 2017-06-30 | $7 |
| 2017-03-31 | $7 |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.181B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.763B | 20.73 |
| Axonics (AXNX) | United States | $3.439B | 0.00 |
| 10x Genomics (TXG) | United States | $3.145B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.107B | 0.00 |
| Azenta (AZTA) | United States | $2.928B | 159.12 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.910B | 0.00 |
| Enovis (ENOV) | United States | $2.800B | 20.75 |
| Hims & Hers Health (HIMS) | United States | $2.768B | 0.00 |
| Privia Health (PRVA) | United States | $2.139B | 120.20 |
| Schrodinger (SDGR) | United States | $1.673B | 0.00 |
| Omnicell (OMCL) | United States | $1.389B | 48.02 |
| Phreesia (PHR) | United States | $1.238B | 0.00 |
| Standard BioTools (LAB) | United States | $0.699B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.652B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.610B | 0.00 |
| Talkspace (TALK) | United States | $0.483B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.428B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.394B | 0.00 |
| Pulmonx (LUNG) | United States | $0.340B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.314B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.231B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.205B | 0.00 |
| Outset Medical (OM) | United States | $0.169B | 0.00 |
| American Well (AMWL) | United States | $0.152B | 0.00 |
| TruBridge (TBRG) | United States | $0.123B | 5.26 |
| Augmedix (AUGX) | United States | $0.122B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
| 111 (YI) | China | $0.095B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.073B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.060B | 0.00 |
| Zepp Health (ZEPP) | China | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| Movano (MOVE) | United States | $0.039B | 0.00 |
| Akili (AKLI) | United States | $0.035B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| CareCloud (CCLD) | United States | $0.021B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |